临床外科杂志 ›› 2023, Vol. 31 ›› Issue (2): 127-131.doi: 10.3969/j.issn.1005-6483.2023.02.008

• 论著 • 上一篇    下一篇

非肌层浸润性膀胱癌经尿道膀胱肿瘤电切术后肿瘤残余病人行二次电切术后复发的危险因素分析

  

  1. 442000 湖北十堰市太和医院泌尿外科(管富勇、王黎、王俊霖、姚启盛)
  • 收稿日期:2022-07-09 修回日期:2022-07-09 接受日期:2022-07-09 出版日期:2023-02-20 发布日期:2023-02-20
  • 通讯作者: 姚启盛,Email:y_qisheng@163.com

Risk factors of recurrence in patients with residual tumor after transurethral resection of bladder tumor for non muscular invasive bladder cancer

  1. Department of Urology,Taihe hospital,Hubei Province,Shiyan City 442000,China
  • Received:2022-07-09 Revised:2022-07-09 Accepted:2022-07-09 Online:2023-02-20 Published:2023-02-20

摘要: 目的 探究非肌层浸润性膀胱癌经尿道膀胱肿瘤电切术(TURBT)术后肿瘤残余病人行二次电切术后复发的危险因素。方法 2020年5月~2021年6月我院收治的非肌层浸润性膀胱癌行TURBT术后肿瘤残余病人100例,随访术后12个月复发情况,并将其分为复发组(15例)和未复发组(85例)。采用多因素Logistic回归分析法分析非肌层浸润性膀胱癌病人二次电切术后复发的危险因素,同时建立Nomogram列线图模型,绘制受试者工作特征曲线分析预测效能。结果 100例非肌层浸润性膀胱癌行二次电切术后随访12个月复发15例,1年复发率15.00%。复发组首次TURBT术前肿瘤多发、肿瘤分期T1期、肿瘤分化程度低分化所占比例均高于未复发组,肿瘤带蒂、二次电切术后卡介苗灌注所占比例均低于未复发组,差异有统计学意义(P<0.05)。Logistic多因素回归分析显示,首次TURBT术前肿瘤多发、肿瘤分期T1期、肿瘤低分化均为二次电切术后复发的危险因素(P<0.05)。二次电切术后卡介苗灌注为二次电切术后复发的保护因素(P<0.05)。列线图预测模型预测非肌层浸润性膀胱癌病人二次电切术后复发的曲线下面积(AUC)为0.759(95%CI:0.641~0.827)。结论 首次TURBT术前肿瘤多发、肿瘤分期T1期、肿瘤低分化均为二次电切术后复发的危险因素,二次电切术后卡介苗灌注为二次电切术后复发的保护因素,列线图模型的建立可用以直观、整体评估病人术后复发风险。

关键词: 非肌层浸润性膀胱癌, 经尿道膀胱肿瘤电切术, 二次电切术, 复发, 危险因素

Abstract: Objective To explore the risk factors of recurrence in patients with residual tumor after transurethral resection of bladder tumor (TURBT) for non muscle invasive bladder cancer.Methods The medical records of 100 patients with residual tumor after TURBT for non muscular invasive bladder cancer treated in our hospital from May 2020 to June 2021 were retrospectively analyzed.The patients were followed up for 12 months,and were divided into recurrence group(15 cases) and non recurrence group(85 cases).Multivariate logistic regression analysis was used to analyze the risk factors of recurrence in patients with non myometrial invasive bladder cancer after secondary resection.Nomogram nomogram model was established,and the working characteristic curve of subjects was drawn to analyze the predictive efficacy.Results 100 cases of non myometrial invasive bladder cancer were followed up for 12 months and 15 cases recurred.The 1-year recurrence rate was 15.00%.The proportion of multiple tumors,tumor stage T1 and low differentiation of tumor in the recurrent group before the first TURBT was higher than that in the non recurrent group,and the proportion of BCG perfusion after tumor pedicle and secondary resection was lower than that in the non recurrent group (P<0.05).The results of logistic regression analysis showed that multiple tumors,tumor stage T1 and low differentiation before the first TURBT were the risk factors for recurrence after the second resection (P<0.05).BCG infusion was the protective factor of recurrence after secondary resection (P<0.05).The area under the curve (AUC) of nomograph prediction model for predicting recurrence after secondary resection of non myometrial invasive bladder cancer was 0.759 (95%CI:0.641 ~ 0.827).Conclusion Multiple tumors before the first TURBT,tumor stage T1 and tumor low differentiation are the risk factors for recurrence after the second resection.BCG perfusion after the second resection is the protective factor for recurrence after the second resection.The establishment of nomogram model can be used to intuitively and comprehensively evaluate the risk of recurrence after the second resection.

Key words: non muscular invasive bladder cancer, transurethral resection of bladder tumor, secondary electrotomy, recurrence, risk factors

[1] 陈勇伟 李昊 黄力 陈从波 王黎 姚启盛. 新辅助化疗联合经尿道膀胱肿瘤电切术对膀胱癌病人肿瘤直径、尿液膀胱肿瘤抗原水平及复发率的影响[J]. 临床外科杂志, 2023, 31(2): 152-155.
[2] 郭佳 朱传想 何伟. 经括约肌间瘘管结扎术联合直肠推移瓣术治疗高位复杂性肛瘘的可行性研究[J]. 临床外科杂志, 2023, 31(1): 74-76.
[3] 莫波 王佩 童宜欣 何志军 梁俊 郝志楠. 膜解剖技术在胃癌根治术中应用的效果分析[J]. 临床外科杂志, 2022, 30(9): 835-838.
[4] 彭启旺 邓浩 李威. 基于LncRNA表达的胃癌病人术后早期复发风险预测模型构建分析[J]. 临床外科杂志, 2022, 30(9): 848-851.
[5] 吴永力 方汉刚 陈静 闫瑞承. 术前外周血微小RNA-21、血管内皮生长-因子、糖类抗原19-9水平与JP3结直肠癌病人临床分期和术后复发转移的关系[J]. 临床外科杂志, 2022, 30(8): 771-774.
[6] 官艳 张国娇 罗茵. 基于机器学习算法构建重症急性胰腺炎病人肠内营养误吸风险的预测模型#br#[J]. 临床外科杂志, 2022, 30(7): 634-638.
[7] 刘琦 万玉文 李晓强. 椎管内麻醉联合超声引导下闭孔神经阻滞与全身麻醉相比对经尿道膀胱肿瘤切除术病人术后肿瘤复发影响的临床研究进展[J]. 临床外科杂志, 2022, 30(6): 506-509.
[8] 姚宝春 邓大溢 方强 陈士洲. 激光与电切术治疗非肌层浸润性膀胱癌的疗效及应激反应程度比较[J]. 临床外科杂志, 2022, 30(6): 579-582.
[9] 刘博豪 张言鹏 陶润仪 王绩钊 范坤 王泓懿 赵恒 李益行 王芝馀 付军科 张佳 张广健. 胸壁恶性肿瘤术后复发分析[J]. 临床外科杂志, 2022, 30(4): 331-334.
[10] 候利华 蔡晓军. 气腹CT腹膜腔三维仿真成像诊断术后腹腔粘连[J]. 临床外科杂志, 2022, 30(4): 349-352.
[11] 陶子夏 丁政 邓先兆 郭伯敏 张颖超 陈承坤 陶玄斌 顾晓辉 樊友本. 甲状腺髓样癌术后复发的外科诊治策略[J]. 临床外科杂志, 2022, 30(3): 213-215.
[12] 张钰晗 薛帅 陈光. 甲状腺髓样癌术后随访与监测[J]. 临床外科杂志, 2022, 30(3): 216-219.
[13] 张传灼 任明 孟达理 王平 王勇. 甲状腺髓样癌颈侧区淋巴结转移的危险因素分析[J]. 临床外科杂志, 2022, 30(3): 230-233.
[14] 向璇 吾甫尔·依马尔 王护国. 甲状腺切除术后甲状旁腺损伤相关危险因素Meta分[J]. 临床外科杂志, 2022, 30(3): 234-238.
[15] 张丰铎 陈晓东 吴泽玉. 血清低氧诱导因子-1α和白细胞介素-6表达预测老年垂体瘤经鼻蝶手术治疗病人复发的临床意义[J]. 临床外科杂志, 2022, 30(2): 142-144.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 贺长林;黎秋曦;刘锋;等. 腹腔镜阑尾切除术中转开腹及再手术的处理体会[J]. 临床外科杂志, 2016, 24(10): 802 .
[2] 朱水波;周孜孜;郗二平等. 不同浓度转化生长因子β1对人主动脉平滑肌细胞增殖及迁移的影响[J]. 临床外科杂志, 2016, 24(5): 366 -0 .
[3] 曾杨军;胡万里;程龙等. 经尿道前列腺等离子双极电切术和电切术治疗良性前列腺增生对性功能影响的Meta分析[J]. 临床外科杂志, 2016, 24(5): 386 -0 .
[4] 叶章群;刘浩然. 泌尿系结石的诊断治疗进展[J]. 临床外科杂志, 2017, 25(2): 85 .
[5] 喻少敏;郭卫春. 二十二碳六烯酸在急性脊髓损伤后早期炎性反应中的作用[J]. 临床外科杂志, 2017, 25(4): 301 .
[6] 刘明新 徐剑军. 医源性胆道损伤13例诊治分析[J]. 临床外科杂志, 2018, 26(10): 777 -779 .
[7] 王国义 梁剑峰 田锦林 鲍峰. 内镜直视与X线透视下支架置入术治疗晚期食管贲门癌临床疗效比较[J]. 临床外科杂志, 2018, 26(9): 679 -682 .
[8] 徐向南 陈寅. 肺癌肺叶切除联合纵隔淋巴结清扫治疗方案使用胸腔镜手术和传统开胸手术方法的比较[J]. 临床外科杂志, 2018, 26(9): 709 -711 .
[9] 林佩达 黄家麒 卢化祥 黄晟 刘光 杨广林 王福音 何冰冰 刘晓兵. 经皮机械性血栓清除术治疗创伤病人下肢深静脉血栓形成的安全性和早期疗效分析[J]. 临床外科杂志, 2018, 26(11): 810 -813 .
[10] 韩衍龙 张诚 陈冬明 潘淼 吴永刚. 内镜手术治疗泌乳素腺瘤52例分析[J]. 临床外科杂志, 2018, 26(11): 831 -834 .